Temanogrel (Standard)

[1]Xiong Y, et al. Discovery and structure-activity relationship of 3-methoxy-N- (3- (1-methyl-1H-pyrazol-5-yl) -4- (2-morpholinoethoxy) phenyl) benzamide (APD791) : a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis. J Med Chem. 2010 Jun 10;53 (11) :4412-21.|[2]Przyklenk K, et al. Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis. J Thromb Haemost. 2010 Feb;8 (2) :331-40.|[3]Adams JW, et al. APD791, 3-methoxy-n- (3- (1-methyl-1h-pyrazol-5-yl) -4- (2-morpholinoethoxy) phenyl) benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology. J Pharmacol Exp Ther. 2009 Oct;331 (1) :96-103.